Selim Jennane
-
- Multiple Myeloma Research and Treatments 3
-
- Chronic Lymphocytic Leukemia Research 4
- Hemoglobinopathies and Related Disorders 2
-
- Lymphoma Diagnosis and Treatment 4
-
- Neurological Complications and Syndromes 2
-
- Viral-associated cancers and disorders 3
-
- CNS Lymphoma Diagnosis and Treatment 4
-
- Brain Metastases and Treatment 2
- Co-authors
- Thierry de RevelJohanna KonopackiBruno VaretBertrand SouleauVincent FoissaudM. El KhorassaniLaila HessissenC. Fendri
- Journals
- SHILAP Revista de lepidopterología (2 papers)Médecine et Maladies Infectieuses (1 paper)Transfusion Clinique et Biologique (1 paper)
In The Last Decade
Selim Jennane
13 papers receiving 40 citations
Peers
Comparison fields: 5 of 30
- Hematology 11
- Genetics 10
- Pathology and Forensic Medicine 15
- Psychiatry and Mental health 6
- Oncology 10
Countries citing papers authored by Selim Jennane
This map shows the geographic impact of Selim Jennane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selim Jennane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selim Jennane more than expected).
Fields of papers citing papers by Selim Jennane
This network shows the impact of papers produced by Selim Jennane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selim Jennane. The network helps show where Selim Jennane may publish in the future.
Co-authorship network
The 9 scholars most cited alongside Selim Jennane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 2 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 0 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 3 | |
| 7 | 2019 | 3 | |
| 8 | 2019 | 0 | |
| 9 | 2014 | 4 | |
| 10 | 2013 | 5 | |
| 11 | 2013 | 2 | |
| 12 | 2013 | 2 | |
| 13 | 2013 | 2 | |
| 14 | 2013 | 1 | |
| 15 | 2012 | 5 | |
| 16 | [Sensitivity of Acinetobacter baumannii to antibiotics and disinfectants used in a Tunisian hospital milieu]. | 1995 | 1 |
About Selim Jennane
Selim Jennane is a scholar working on Genetics, Applied Microbiology and Biotechnology and Hematology, having authored 16 papers that have together received 40 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Multiple Myeloma Research and Treatments (3 papers), Viral-associated cancers and disorders (3 papers), Neurological Complications and Syndromes (2 papers), Brain Metastases and Treatment (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). The work is most often cited by research in Hematology (11 citations), Genetics (10 citations) and Pathology and Forensic Medicine (15 citations). Selim Jennane has collaborated with scholars based in Morocco, France and Pakistan. Frequent co-authors include Thierry de Revel, Johanna Konopacki, Bruno Varet, Bertrand Souleau, Vincent Foissaud, M. El Khorassani, Laila Hessissen, C. Fendri and Abdellatif Boudabous. Their work appears in journals such as SHILAP Revista de lepidopterología, Médecine et Maladies Infectieuses and Transfusion Clinique et Biologique.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.